Skip to Content

Deva Holding AS DEVA

Morningstar Rating
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

DEVA is trading at a 780% premium.
Price
TRY 90.88
Fair Value
TRY 377.83
Uncertainty
Very High
1-Star Price
TRY 395.48
5-Star Price
TRY 26.97
Economic Moat
Pflrm
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if DEVA is a good fit for your portfolio.

Trading Information

Previous Close Price
Day Range
52-Week Range
Bid/Ask
/
Market Cap
Volume/Avg
/

Key Statistics

Price/Earnings (Normalized)
4.09
Price/Sales
159.76
Dividend Yield (Trailing)
0.17%
Dividend Yield (Forward)
0.28%
Total Yield
0.17%

Company Profile

Deva Holding AS is a Turkey-based generic medicine manufacturer. It is engaged in manufacturing and marketing of medicinal products for human use and raw materials. The company also carries out the manufacturing of veterinary drugs, eau de cologne, and medical ampoules. It produces medicines for antineoplastic agents, cardiovascular system, dermatological products, nervous system, respiratory system, urogenital system, among others. It exports pharmaceuticals and pharmaceutical raw materials in countries including Switzerland, Germany, the Netherlands, the United Kingdom and others.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Growth
Total Number of Employees
2,908

Comparables

Valuation

Metric
DEVA
300194
000020
Price/Earnings (Normalized)
4.0915.8016.28
Price/Book Value
1.221.090.62
Price/Sales
159.761.720.60
Price/Cash Flow
1,099.338.635.39
Price/Earnings
DEVA
300194
000020

Financial Strength

Metric
DEVA
300194
000020
Quick Ratio
1.031.181.58
Current Ratio
1.661.772.33
Interest Coverage
2.1610.9632.26
Quick Ratio
DEVA
300194
000020

Profitability

Metric
DEVA
300194
000020
Return on Assets (Normalized)
26.70%0.94%3.67%
Return on Equity (Normalized)
49.22%1.40%5.02%
Return on Invested Capital (Normalized)
38.23%1.12%3.52%
Return on Assets
DEVA
300194
000020
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Merck KGaA ADR
MKKGY
DcnhqvpysKpqshvq$80.3 Bil
Zoetis Inc Class A
ZTS
CwnndlstlZzsq$77.8 Bil
Haleon PLC ADR
HLN
ZrfshdzkVfr$37.8 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
RyhrqlcxTgmxk$12.1 Bil
Viatris Inc
VTRS
LfpvmsnpJdfs$12.1 Bil
Catalent Inc
CTLT
GvbdlpgQjhynl$10.0 Bil
Perrigo Co PLC
PRGO
ZrypzxglCzj$3.7 Bil
Prestige Consumer Healthcare Inc
PBH
XqnhjrcpDwzncm$3.2 Bil
Curaleaf Holdings Inc
CURLF
YlkxlcqzsQdyn$3.0 Bil
Green Thumb Industries Inc
GTBIF
KjtcjghtspKddz$2.7 Bil

Sponsor Center